Research library
Peptides Research Team
-

TB-500 (Thymosin Beta-4): Research, Mechanism, Risks & Legal Status (2026)
An evidence-graded overview of TB-500: what the marketed peptide actually is, what the actin-sequestering research shows, the documented risks, and where US…
-

CJC-1295 (with and without DAC): Research, Mechanism, Risks & Legal Status (2026)
An evidence-graded overview of CJC-1295: why the DAC and no-DAC forms are different molecules with very different evidence, what the ConjuChem human…
-

Healing Peptides for Recovery & Tissue Repair: What the Evidence Shows
An evidence-graded hub for the recovery and tissue-repair cluster: BPC-157, TB-500 and thymosin beta-4, GHK-Cu and KPV, with the animal-versus-human split made…
-

What Are Peptides? A Plain-English Guide (2026)
A plain-English, referenced introduction to peptides: what they are, how they differ from proteins, how peptide drugs work, and how to judge…
-

Tirzepatide: Research, Mechanism, Risks & Legal Status (2026)
An evidence-graded overview of tirzepatide: dual GIP/GLP-1 receptor pharmacology, what the SURPASS and SURMOUNT trials found, documented risks, and its 2026 regulatory…
-

Are Peptides Legal? US Regulatory Status in 2026
A date-stamped guide to US peptide regulation in 2026: the FD&C Act framework, 503A and 503B compounding, the bulk drug substances lists,…
-

How to Read a Peptide Certificate of Analysis (COA)
A field guide to reading a peptide certificate of analysis line by line — purity by HPLC, identity by mass spectrometry, peptide…
-

Semaglutide: Research, Mechanism, Risks & Legal Status (2026)
An evidence-graded reference on semaglutide: structure, GLP-1 receptor mechanism, the human RCT programmes, labelled risks, and the 2026 US regulatory and compounding…
-

Growth Hormone Secretagogue Peptides Explained: GHRH vs GHRP
The hub page for the GH cluster: how GHRH analogues and ghrelin-receptor agonists differ mechanistically, what human evidence exists for each, and…
-

GLP-1 and Incretin Peptides Explained: Semaglutide, Tirzepatide, Retatrutide & More
A hub guide to the incretin class: how GLP-1, GIP and glucagon receptor agonists work, which are approved, what the trials found,…